NewslettersDermal Cell NewsSaracatinib Inhibits Necroptosis and Ameliorates Psoriatic Inflammation by Targeting MLKLBy Laurisa Dohm - February 12, 2024071In an imiquimod-induced psoriasis mouse model, saracatinib effectively blocked mixed lineage kinase domain-like protein (MLKL) phosphorylation and inflammatory responses in vivo.[Cell Death & Disease]Full Article